Granite Investment Partners, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1542266 EL SEGUNDO, CA

Position in IONS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$398,511

-$2,845 QoQ

Shares Held

5,026

-6.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#315

of 510 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Granite Investment Partners, LLC holds $85,167,773 across 14 Biotechnology names. IONS ranks #8 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	80,124	$19,611,951
2	LGND	Ligand Pharmaceuticals Inc	54,128	$17,109,319
3	CORT	Corcept Therapeutics Inc	172,228	$14,975,224
4	KRYS	Krystal Biotech, Inc.	32,837	$12,204,527
5	TECH	BIO-TECHNE Corp	133,572	$9,436,861
6	VCEL	Vericel Corp	121,696	$5,414,255
7	HALO	Halozyme Therapeutics, Inc.	63,598	$4,977,815
8	IONS	Ionis Pharmaceuticals Inc This page	5,026	$398,511

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$398,511	5,026	-6.0%	Shares	Sole	2026-08-07
2026-03-31	$401,356	5,345	+11.2%	Shares	Sole	2026-04-30
2025-12-31	$380,202	4,806	-82.9%	Shares	Sole	2026-02-12
2025-09-30	$1,833,918	28,033	-35.1%	Shares	Sole	2025-11-10
2025-06-30	$1,706,081	43,181	-36.9%	Shares	Sole	2025-08-13
2025-03-31	$2,064,653	68,434	-7.4%	Shares	Sole	2025-05-13
2024-12-31	$2,582,355	73,866	-13.9%	Shares	Sole	2025-02-13
2024-09-30	$3,436,867	85,793	-24.8%	Shares	Sole	2024-11-12
2024-06-30	$5,437,529	114,090	-1.8%	Shares	Sole	2024-08-12
2024-03-31	$5,034,842	116,144	-3.2%	Shares	Sole	2024-05-13
2023-12-31	$6,068,068	119,946	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.